FerroKin Biosciences
About:
Ferrokin Biosciences develops and markets medical devices such as Iron Chelator for the treatment of iron-overload in patients.
Top Investors: MP Healthcare Venture Management, Celgene, HealthCap, Clarus Ventures, Burrill & Company
Description:
Ferrokin Biosciences Inc. develops and markets medical devices. The company offers iron chelator for the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemias. The company is based in San Carlos, California.
Total Funding Amount:
$30M
Headquarters Location:
Lexington, Massachusetts, United States
Founded Date:
2007-01-01
Founders:
Hugh Rienhoff
Number of Employees:
1-10
Last Funding Date:
2012-02-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai